Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran PK/PD in Children 1-2 Years with VTE
NCT01773174Phase 2Withdrawn
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dabigatran in venous thromboembolism (VTE), sponsored by Boehringer Ingelheim. Planned start Jan 2013; status: withdrawn.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01773174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01773174.